BRIANA BLUM: Open Payments
NPI 1588998561 · JACKSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,461 in 83 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $440 · 2025 $1,461
Food & beverage: $1,461
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $203 |
| Novartis Pharmaceuticals Corporation | 11 | $164 |
| PFIZER INC. | 8 | $143 |
| E.R. Squibb & Sons, L.L.C. | 13 | $142 |
| Merck Sharp & Dohme LLC | 6 | $127 |
| Alnylam Pharmaceuticals Inc. | 4 | $106 |
| Novo Nordisk Inc | 5 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| Corcept Therapeutics | 3 | $52 |
| BridgeBio Pharma, Inc. | 2 | $45 |
Products named: ELIQUIS, JARDIANCE, LEQVIO, VERQUVO, ONPATTRO, Kerendia, CAMZYOS, Ozempic.
Industry payments across MI — which companies pay providers there.
